Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast cancer in BRCA mutation carriers: medical treatment.

Minerva ginecologica - 1 Oct 2016

Milani Andrea, Geuna Elena, Zucchini Giorgia, Aversa Caterina, Martinello Rossella, Montemurro Filippo

Abstract excerpt

About 10% of breast cancers are associated with the inheritance of autosomal dominant breast cancer susceptibility alleles BRCA1 and BRCA2. Until recently, the medical management of BRCA mutation-associated breast cancer has not differed from that of the sporadic breast cancer counterpart. However, there is mounting evidence that this molecular alteration confers sensitivity or resistance to systemic therapies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to BRCA1 gene

Share to BRCA2 gene

Share to Molecular Targeted Therapy

Share to Mutation

Source

Identifiers

PMID: 26799758

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast cancer in BRCA mutation carriers: medical treatment.PMID 26799758Read ↗

Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier.Semantic proximity Read ↗

BRCA1/2 testing: therapeutic implications for breast cancer managementSemantic proximity Read ↗

Therapeutic approaches for women predisposed to breast cancer.Semantic proximity Read ↗

Systemic therapy options in BRCA mutation-associated breast cancer.Semantic proximity Read ↗

Treatment of women with BRCA mutation.Semantic proximity Read ↗

Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms.Semantic proximity Read ↗

Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?Semantic proximity Read ↗

Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?Semantic proximity Read ↗

PARP Pioneers: Using BRCA1/2 Mutation-targeted Inhibition to Revolutionize Breast Cancer TreatmentSemantic proximity Read ↗

Hereditary breast and ovarian cancer: from genes to molecular targeted therapies.Semantic proximity Read ↗

Clinical management of hereditary breast cancer syndromes.Semantic proximity Read ↗

An overview of the research progress of BRCA gene mutations in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.